| # | Drug | Count |
|---|---|---|
| 0 | ERLOTINIB | 21 |
| 1 | ERLOTINIB HYDROCHLORIDE | 21 |
| 2 | SIMVASTATIN | 13 |
| 3 | ESOMEPRAZOLE | 11 |
| 4 | ESOMEPRAZOLE MAGNESIUM | 11 |
| 5 | VENLAFAXINE | 10 |
| 6 | VENLAFAXINE HYDROCHLORIDE | 10 |
| 7 | BUPROPION | 9 |
| 8 | LANSOPRAZOLE | 8 |
| 9 | OSIMERTINIB | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ERLOTINIB HYDROCHLORIDE | 21 | 0.0017 |
| 1 | OSIMERTINIB | 8 | 0.0002 |
| 2 | FLUOXETINE HCL | 1 | 0.0002 |
| 3 | LOTEPREDNOL ETABONATE | 1 | 0.0002 |
| 4 | VINORELBINE | 1 | 0.0001 |
| 5 | ESOMEPRAZOLE MAGNESIUM DIHYDRATE | 2 | 0.0001 |
| 6 | PYRAZINAMIDE | 1 | 0.0001 |
| 7 | RIFAMPICIN | 1 | 0.0001 |
| 8 | VENLAFAXINE HYDROCHLORIDE | 10 | 0.0001 |
| 9 | SIMVASTATIN | 13 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimycobacterial [EPC] | 1 | 0.0000 |
| 1 | HMG-CoA Reductase Inhibitor [EPC] | 13 | 0.0000 |
| 2 | Proton Pump Inhibitor [EPC] | 16 | 0.0000 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 4 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 1 | 0.0000 |
| 5 | Tetracycline-class Drug [EPC] | 1 | 0.0000 |
| 6 | Serotonin Reuptake Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Platinum-based Drug [EPC] | 3 | 0.0000 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 9 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 1 | 0.0000 |